Security record · archived quarter
HSIC
Henry Schein, Inc. · Healthcare · Medical - Distribution
2Tracked holders
0Δ holders
111.18KShares held
$9.14MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 111.18K | $9.14M | n/a | n/a |
| Q2 2026 | 140 | +5 | 77.20M | $6.45B | +10 | −6 |
| Q1 2026 | 139 | +3 | 72.55M | $5.34B | +6 | −4 |
| Q4 2025 | 135 | -2 | 77.59M | $5.86B | +2 | −3 |
| Q3 2025 | 21 | +1 | 46.40M | $3.08B | +2 | −2 |
| Q2 2025 | 18 | -1 | 35.28M | $2.58B | +1 | −2 |
| Q1 2025 | 16 | 0 | 11.46M | $784.56M | +2 | −2 |
| Q4 2024 | 16 | 0 | 13.10M | $906.08M | n/a | n/a |
| Q3 2024 | 15 | 0 | 6.23M | $453.14M | +1 | −1 |
| Q2 2024 | 15 | n/a | 6.78M | $433.78M | n/a | n/a |
Who holds it · Q3 2026
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Assenagon Asset Management S.A. | 68.08K | -20.2% | $5.72M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 43.10K | +14.0% | $3.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 555 holders, 115.73M shares, $8.30B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Aug 06
SC 13G: FMR LLC
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2026 ·
Methodology ·
Get this via the API